This research is being done to evaluate the safety and effectiveness of the drug NIS793 in
combination with the standard of care treatment FOLFIRINOX (consists of the drugs
5-Fluorouracil (5-FU), Oxaliplatin, Irinotecan, and Leucovorin), chemoradiation and surgery
for people with metastatic pancreas adenocarcinoma.
The drugs involved in this study are:
- NIS793
- FOLFIRINOX (consists of the drugs 5-Fluorouracil (5-FU), Oxaliplatin, Irinotecan, and
Leucovorin)
Other interventions include
- chemoradiation
- surgery.